The main scientific theme of this project is to determine if the genetic epidemiology of Parkinson's disease (PD) is consistent with an etiologic role for inherited abnormalities of mitochondrial DNA (mtDNA). The presence of a mitochondrial complex I defect in subjects with PD is now well established. Furthermore, this defect appears to arise as a consequence of abnormalities in mtDNA. Whether these abnormalities of mtDNA are acquired or inherited is not known, but we have recently shown in a multi-generational family with PD in which transmission has been exclusively along maternal lines that maternal offspring have lower Complex I activity than paternal offspring. In Project 3 we will use data on family history of PD in PD subjects and controls generated by the Subject Accrual and Ascertainment component of the Core. These data will be examined to test three hypotheses regarding the role of mtDNA mutations in particular, and genetic risk factors in general, in the etiology of PD. Hypothesis 1: There is a predominance of maternal inheritance in PD. If inherited mtDNA mutations play a role in PD etiology, one would predict an excess of maternal inheritance. We will compare directly the number of affected mothers and fathers of probands using survival analysis. Logistic regression will be used to evaluate the influence of the gender of affected parents when probands have both an affected sibling and an affected parent, and to determine the relative risk of developing PD between PD subjects and controls when there is an affected mother versus an affected father. Hypothesis 2: Parkinson's disease susceptibility is determined by a major gene. We will perform a complex segregation analysis of a series of consecutively ascertained nuclear genetic families. Hypothesis 3: Certain disease characteristics of PD may be associated with familial or non-familial PD. Using logistic regression and analysis of variance, we will address the question of whether early age of onset, gender, or rapid symptom progression in PD is associated with a positive family history.
National Institute of Neurological Disorders and Stroke
CFDA Code
DUNS Number
065391526
UEI
JJG6HU8PA4S5
Project Start Date
01-August-2002
Project End Date
31-July-2003
Budget Start Date
Budget End Date
Project Funding Information for 2002
Total Funding
$231,922
Direct Costs
$231,922
Indirect Costs
Year
Funding IC
FY Total Cost by IC
2002
National Institute of Neurological Disorders and Stroke
$231,922
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5P50NS039788-04 0003
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P50NS039788-04 0003
Patents
No Patents information available for 5P50NS039788-04 0003
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P50NS039788-04 0003
Clinical Studies
No Clinical Studies information available for 5P50NS039788-04 0003
News and More
Related News Releases
No news release information available for 5P50NS039788-04 0003
History
No Historical information available for 5P50NS039788-04 0003
Similar Projects
No Similar Projects information available for 5P50NS039788-04 0003